Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal International Journal of Health and Pharmaceutical (IJHP)
Lalu Viska Suhendra
Kelompok Staf Medis Bedah Rumah Sakit Umum Daerah Banten, Indonesia
Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Right Breast Carcinoma with Serosanguinous Ulcer in a 65-Year-Old Female: A Case Report Lalu Viska Suhendra; Ifsi Misilanti Dewi; Arif Kurniawan
International Journal of Health and Pharmaceutical (IJHP) Vol. 6 No. 2 (2026): May 2026
Publisher : CV. Inara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51601/ijhp.v6i2.653

Abstract

Breast cancer is the most common malignancy among women worldwide. While most cases present with a palpable mass, cutaneous involvement such as ulceration and serosanguinous discharge is less commonly emphasized and may delay diagnosis, particularly in elderly patients. A 65-year-old female presented with a five-year history of a progressively enlarging right breast lump that had recently ulcerated with serosanguinous and purulent discharge, accompanied by fever, nausea, and anorexia. She had no prior medical evaluation for the mass. Vital signs were stable except for tachycardia (110 bpm). Laboratory findings revealed marked leukocytosis (31.2 × 10³/µL), mild hyponatremia (133 mEq/L), and stage 2 chronic kidney disease (eGFR 60 mL/min/1.73 m²). Core needle biopsy of the breast mass demonstrated invasive carcinoma of no special type (NST), grade III, with no lymphovascular invasion and low tumor infiltrating lymphocytes (<5%). Initial management included intravenous ceftriaxone, analgesics, antiemetics, and wound care. This case highlights the importance of prompt histopathologic diagnosis in ulcerated breast lesions to differentiate malignancy from benign conditions. Delayed presentation remains a challenge in elderly populations. Comprehensive oncologic staging and definitive multimodality therapy are essential for optimal outcomes.
Co-Authors Arif Kurniawan Ifsi Misilanti Dewi